Andrew D. Penman


Andrew D. Penman, Ph.D., FRSC
Vice President
Drug Development
Southern Research Institute

Lunch Keynote Speaker

“In November 2008, Andrew D. Penman, Ph.D., was named Vice President of the Drug Development Division at Southern Research. In this position, he leads the preclinical contract research operations in toxicology, bioanalytical sciences, infectious diseases, cancer therapeutics, and immunology. Before joining Southern Research, Dr Penman served as vice president of Preclinical Development for Angiotech Inc. in Canada where he directed the company’s global preclinical research and development activities focusing on a number of different therapeutic areas. He also led the company’s Vascular WrapTM project team for a product in Phase III clinical trials. Prior to that, Dr Penman was President of Preclinical Technologies at Aptuit. He also held scientific management positions at Pharmacia (now part of Pfizer) in the US, Cephac Europe SA in France, and Quintiles in the UK and US. Dr. Penman earned his Bachelor’s degree in chemistry from Heriot-Watt University in Edinburgh, Scotland and his Doctorate degree from the University of Kent in the United Kingdom. He is a Fellow of the Royal Society of Chemistry, has made numerous scientific presentations and is author or co-author on a number of scientific publications.”

Posted in 2014 Invited Speakers